For patients with sepsis, time to effective and optimised therapy is critical.
Accelerate Diagnostics has created breakthrough diagnostic solutions by developing technologies that address the needs of clinicians. Accelerate Diagnostics work with healthcare partners across the globe to ensure our innovations lead to critical answers that drive improved treatment options for patients.
The Accelerate Pheno system delivers definitive antibiotic susceptibility results, with MICs, direct from positive blood cultures 1 to 2 days earlier than conventional methods allowing institutions to:
- Escalate to effective therapy sooner
- Optimise and de-escalate therapy earlier
- Improve patient outcomes and reduce healthcare costs
- Support antimicrobial stewardship and infection control efforts
- Reduce antibiotic resistance